Yann Christinat
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.
Journal: JCO precision oncology
Published: July 02, 2025
BRCA2 germline mutation carrier with five malignancies: a case report.
Journal: Hereditary cancer in clinical practice
Published: August 29, 2024
Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology.
Journal: Virchows Archiv : an international journal of pathology
Published: August 07, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.
Journal: JCO precision oncology
Published: March 21, 2024
Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma.
Journal: JCO precision oncology
Published: June 26, 2023
Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab.
Journal: Gynecologic oncology reports
Published: February 12, 2021
Automated Detection of Arm-Level Alterations for Individual Cancer Patients in the Clinical Setting.
Automated Detection of Arm-Level Alterations for Individual Cancer Patients in the Clinical Setting.
Journal: The Journal of molecular diagnostics : JMD
Published: February 03, 2021
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer.
Journal: Cell reports
Published: November 26, 2020
Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: April 16, 2020
Tissue-Plasma TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.
Journal: Frontiers in oncology
Published: December 05, 2019
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss.
Journal: Cancer biology & therapy
Published: November 12, 2019
Targeted RNA-sequencing identifies FBXW4 instead of MGEA5 as fusion partner of TGFBR3 in pleomorphic hyalinizing angiectatic tumor.
Journal: Virchows Archiv : an international journal of pathology
Published: January 08, 2019
Last Updated: 09/26/2026